Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems

Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the chal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Veterinary Pathology 2010, Vol.47 (1), p.58-76
1. Verfasser: Perkins, L.E. Leigh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue 1
container_start_page 58
container_title Veterinary Pathology
container_volume 47
creator Perkins, L.E. Leigh
description Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.
doi_str_mv 10.1177/0300985809352978
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733791406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0300985809352978</sage_id><sourcerecordid>733791406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq2Kqmxp7z2Bb5zSju3Edo4Ith8SVasunC0nGS9G3nixEyT-fb0K5cChp5FmnveR5iXkE4PPjCn1BQRAqxsNrWh4q_QbsmJNXVecM3VEVodzdbgfk_c53wNw3mr1jhxzAA21livififsgx99bwP9GQcMmUZH_2CecIzZZ2rHgd7coU_0Yr8PhZt8HKkf6XSHdP1ow7xsSuoqzdtqHebJj1u6KYKJbp6KaJc_kLfOhowfn-cJuf26vrn8Xl3_-vbj8uK66mvgU8U7ENg0XdO5Xgy9At0hxxakRDeoFpizHQfBmGxt10jZ9SBRI3BRO944IU7I-eLdp_gwlyfMzuceQ7AjxjkbJYRqWQ2ykLCQfYo5J3Rmn_zOpifDwBzKNa_LLZHTZ_nc7XB4CfxrswDVAmS7RXMf5zSWZ_8nPFt4Z6Ox2-Szud1wYAKYZpzLWvwFF52K0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733791406</pqid></control><display><type>article</type><title>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Perkins, L.E. Leigh</creator><creatorcontrib>Perkins, L.E. Leigh</creatorcontrib><description>Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.</description><identifier>ISSN: 0300-9858</identifier><identifier>EISSN: 1544-2217</identifier><identifier>DOI: 10.1177/0300985809352978</identifier><identifier>PMID: 20080486</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>animal disease models ; Animals ; coronary artery disease ; Coronary Disease - therapy ; Coronary Restenosis - prevention &amp; control ; Coronary Restenosis - therapy ; coronary vessels ; Disease Models, Animal ; Dogs ; drug delivery systems ; Drug-Eluting Stents - adverse effects ; endovascular stents ; equipment performance ; in-stent restenosis ; literature reviews ; medical equipment ; medical treatment ; Mice ; pathophysiology ; percutaneous coranary intervention ; Primates ; Rabbits ; Rats ; Sheep ; Swine ; transdermal application ; vascular diseases</subject><ispartof>Veterinary Pathology, 2010, Vol.47 (1), p.58-76</ispartof><rights>The American College of Veterinary Pathologists 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</citedby><cites>FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0300985809352978$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0300985809352978$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>313,314,776,780,788,4009,21799,27901,27902,27903,27904,43600,43601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20080486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perkins, L.E. Leigh</creatorcontrib><title>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</title><title>Veterinary Pathology</title><addtitle>Vet Pathol</addtitle><description>Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.</description><subject>animal disease models</subject><subject>Animals</subject><subject>coronary artery disease</subject><subject>Coronary Disease - therapy</subject><subject>Coronary Restenosis - prevention &amp; control</subject><subject>Coronary Restenosis - therapy</subject><subject>coronary vessels</subject><subject>Disease Models, Animal</subject><subject>Dogs</subject><subject>drug delivery systems</subject><subject>Drug-Eluting Stents - adverse effects</subject><subject>endovascular stents</subject><subject>equipment performance</subject><subject>in-stent restenosis</subject><subject>literature reviews</subject><subject>medical equipment</subject><subject>medical treatment</subject><subject>Mice</subject><subject>pathophysiology</subject><subject>percutaneous coranary intervention</subject><subject>Primates</subject><subject>Rabbits</subject><subject>Rats</subject><subject>Sheep</subject><subject>Swine</subject><subject>transdermal application</subject><subject>vascular diseases</subject><issn>0300-9858</issn><issn>1544-2217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhq2Kqmxp7z2Bb5zSju3Edo4Ith8SVasunC0nGS9G3nixEyT-fb0K5cChp5FmnveR5iXkE4PPjCn1BQRAqxsNrWh4q_QbsmJNXVecM3VEVodzdbgfk_c53wNw3mr1jhxzAA21livififsgx99bwP9GQcMmUZH_2CecIzZZ2rHgd7coU_0Yr8PhZt8HKkf6XSHdP1ow7xsSuoqzdtqHebJj1u6KYKJbp6KaJc_kLfOhowfn-cJuf26vrn8Xl3_-vbj8uK66mvgU8U7ENg0XdO5Xgy9At0hxxakRDeoFpizHQfBmGxt10jZ9SBRI3BRO944IU7I-eLdp_gwlyfMzuceQ7AjxjkbJYRqWQ2ykLCQfYo5J3Rmn_zOpifDwBzKNa_LLZHTZ_nc7XB4CfxrswDVAmS7RXMf5zSWZ_8nPFt4Z6Ox2-Szud1wYAKYZpzLWvwFF52K0A</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Perkins, L.E. Leigh</creator><general>SAGE Publications</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</title><author>Perkins, L.E. Leigh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-2b03e55b5bfc3dc708be2e9066efd7901fab2031169ab566bc06e8e0234f25f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>animal disease models</topic><topic>Animals</topic><topic>coronary artery disease</topic><topic>Coronary Disease - therapy</topic><topic>Coronary Restenosis - prevention &amp; control</topic><topic>Coronary Restenosis - therapy</topic><topic>coronary vessels</topic><topic>Disease Models, Animal</topic><topic>Dogs</topic><topic>drug delivery systems</topic><topic>Drug-Eluting Stents - adverse effects</topic><topic>endovascular stents</topic><topic>equipment performance</topic><topic>in-stent restenosis</topic><topic>literature reviews</topic><topic>medical equipment</topic><topic>medical treatment</topic><topic>Mice</topic><topic>pathophysiology</topic><topic>percutaneous coranary intervention</topic><topic>Primates</topic><topic>Rabbits</topic><topic>Rats</topic><topic>Sheep</topic><topic>Swine</topic><topic>transdermal application</topic><topic>vascular diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perkins, L.E. Leigh</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary Pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perkins, L.E. Leigh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems</atitle><jtitle>Veterinary Pathology</jtitle><addtitle>Vet Pathol</addtitle><date>2010</date><risdate>2010</risdate><volume>47</volume><issue>1</issue><spage>58</spage><epage>76</epage><pages>58-76</pages><issn>0300-9858</issn><eissn>1544-2217</eissn><abstract>Coronary arterial disease (CAD) is the leading cause of death in the United States, the European Union, and Canada. Percutaneous coronary intervention (PCI) has revolutionized the treatment of CAD, and it is the advent of drug-eluting stent (DES) systems that has effectively allayed much of the challenge of restenosis that has plagued the success of PCI through its 30-year history. However, DES systems have not been a panacea: There yet remain the challenges associated with interventions involving bare metallic stents as well as newly arisen concerns related to the application of DES systems. To effectively address these novel and ongoing issues, animal models are relied on both to project the safety and efficacy of endovascular devices and to provide insight into the pathophysiology underlying the vascular response to injury and mechanisms of restenosis. In this review, preclinical models of restenosis are presented, and their application and limitation in the evaluation of device-based interventional technologies for the treatment of CAD are discussed.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>20080486</pmid><doi>10.1177/0300985809352978</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-9858
ispartof Veterinary Pathology, 2010, Vol.47 (1), p.58-76
issn 0300-9858
1544-2217
language eng
recordid cdi_proquest_miscellaneous_733791406
source MEDLINE; SAGE Complete A-Z List
subjects animal disease models
Animals
coronary artery disease
Coronary Disease - therapy
Coronary Restenosis - prevention & control
Coronary Restenosis - therapy
coronary vessels
Disease Models, Animal
Dogs
drug delivery systems
Drug-Eluting Stents - adverse effects
endovascular stents
equipment performance
in-stent restenosis
literature reviews
medical equipment
medical treatment
Mice
pathophysiology
percutaneous coranary intervention
Primates
Rabbits
Rats
Sheep
Swine
transdermal application
vascular diseases
title Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T12%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preclinical%20Models%20of%20Restenosis%20and%20Their%20Application%20in%20the%20Evaluation%20of%20Drug-Eluting%20Stent%20Systems&rft.jtitle=Veterinary%20Pathology&rft.au=Perkins,%20L.E.%20Leigh&rft.date=2010&rft.volume=47&rft.issue=1&rft.spage=58&rft.epage=76&rft.pages=58-76&rft.issn=0300-9858&rft.eissn=1544-2217&rft_id=info:doi/10.1177/0300985809352978&rft_dat=%3Cproquest_cross%3E733791406%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733791406&rft_id=info:pmid/20080486&rft_sage_id=10.1177_0300985809352978&rfr_iscdi=true